Inventor · disambiguated record
Joon Bok Lee
Also filed as: LEE JOON BOK
40 granted patents·84 pending applications·33 citations·filing 2015–2025
96Inventor score
Top patents by PatentIndex Score
124 records- 0194US11547800B2User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas systemINSULET CORP·Filed 2020·Granted Jan 10, 2023·4 cites·30 claims
- 0293US11607493B2Initial total daily insulin setting for user onboardingINSULET CORP·Filed 2020·Granted Mar 21, 2023·4 cites·20 claims
- 0392US11738144B2Techniques enabling adaptation of parameters in aid systems by user inputINSULET CORP·Filed 2022·Granted Aug 29, 2023·8 cites·20 claims
- 0490US11957875B2Techniques and devices providing adaptivity and personalization in diabetes treatmentINSULET CORP·Filed 2020·Granted Apr 16, 2024·2 cites·20 claims
- 0588US11324889B2Compensation for missing readings from a glucose monitor in an automated insulin delivery systemINSULET CORP·Filed 2020·Granted May 10, 2022·2 cites·20 claims
- 0686US12226612B2Compensation for missing readings from a glucose monitor in an automated insulin delivery systemINSULET CORP·Filed 2022·Granted Feb 18, 2025·1 cites·20 claims
- 0784US11565043B2Safety constraints for a control algorithm based drug delivery systemINSULET CORP·Filed 2019·Granted Jan 31, 2023·4 cites·20 claims
- 0883US12257420B2Initial total daily insulin setting for user onboardingINSULET CORP·Filed 2024·Granted Mar 25, 2025·0 cites·20 claims
- 0983US11833329B2Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patternsINSULET CORP·Filed 2020·Granted Dec 5, 2023·1 cites·16 claims
- 1083US2025339617A1Adaptive update of automatic insulin delivery (aid) control parametersINSULET CORP·Filed 2025·Application pending·0 cites
- 1182US12343501B2Techniques to reduce risk of occlusions in drug delivery systemsINSULET CORP·Filed 2023·Granted Jul 1, 2025·0 cites·20 claims
- 1282US2025303061A1Techniques to reduce risk of occlusions in drug delivery systemsINSULET CORP·Filed 2025·Application pending·0 cites
- 1380US11628251B2Activity mode for artificial pancreas systemINSULET CORP·Filed 2019·Granted Apr 18, 2023·3 cites·20 claims
- 1480US2024366873A1Model-Based Personalization Scheme of an Artificial Pancreas for Type I Diabetes ApplicationsUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 1580US2024399059A1Safety constraints for a control algorithm based drug delivery systemINSULET CORP·Filed 2024·Application pending·0 cites
- 1679US2024165328A1Adaptable asymmetric medicament cost component in a control system for medicament deliveryINSULET CORP·Filed 2024·Application pending·0 cites
- 1778US12496399B2Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia riskINSULET CORP·Filed 2024·Granted Dec 16, 2025·0 cites·16 claims
- 1878US11911596B2Initial total daily insulin setting for user onboardingINSULET CORP·Filed 2023·Granted Feb 27, 2024·0 cites·20 claims
- 1978US11883632B2Safety constraints for a control algorithm based drug delivery systemINSULET CORP·Filed 2023·Granted Jan 30, 2024·0 cites·20 claims
- 2078US2023372613A1Customization of a glucose prediction model for a user in an automated insulin delivery (aid) deviceINSULET CORP·Filed 2023·Application pending·0 cites
- 2177US12121701B2Systems and methods for incorporating co-formulations of insulin in an automatic insulin delivery systemINSULET CORP·Filed 2022·Granted Oct 22, 2024·0 cites·5 claims
- 2277US2025205427A1Initial total daily insulin setting for user onboardingINSULET CORP·Filed 2025·Application pending·0 cites
- 2377US2024185980A1Onboarding and total daily insulin adaptivityINSULET CORP·Filed 2024·Application pending·0 cites
- 2477US2023377706A1Methods and systems for dynamically customizing insulin on board profiles and providing recommendations to improve the duration of insulin actionINSULET CORP·Filed 2023·Application pending·0 cites
- 2576US12433998B2Activity mode for artificial pancreas systemINSULET CORP·Filed 2023·Granted Oct 7, 2025·0 cites·18 claims
- 2676US12409270B2Optimizing embedded formulations for drug deliveryINSULET CORP·Filed 2022·Granted Sep 9, 2025·0 cites·20 claims
- 2775US12427251B2User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas systemINSULET CORP·Filed 2022·Granted Sep 30, 2025·0 cites·20 claims
- 2875US12102796B2Model-based personalization scheme of an artificial pancreas for type I diabetes applicationsUNIV CALIFORNIA·Filed 2021·Granted Oct 1, 2024·0 cites·4 claims
- 2975US11935637B2Onboarding and total daily insulin adaptivityINSULET CORP·Filed 2019·Granted Mar 19, 2024·1 cites·14 claims
- 3075US2024252751A1Activity mode for artificial pancreas systemINSULET CORP·Filed 2024·Application pending·0 cites
- 3174US11439754B1Optimizing embedded formulations for drug deliveryINSULET CORP·Filed 2021·Granted Sep 13, 2022·0 cites·20 claims
- 3274US2025025631A1Open-loop insulin delivery basal parameters based on insulin delivery recordsINSULET CORP·Filed 2024·Application pending·0 cites
- 3373US12370309B2Adaptive update of automatic insulin delivery (AID) control parametersINSULET CORP·Filed 2022·Granted Jul 29, 2025·0 cites·17 claims
- 3473US12300375B2Early meal detection and calorie intake detectionINSULET CORP·Filed 2023·Granted May 13, 2025·0 cites·20 claims
- 3573US11904140B2Adaptable asymmetric medicament cost component in a control system for medicament deliveryINSULET CORP·Filed 2021·Granted Feb 20, 2024·0 cites·23 claims
- 3673US2024252753A1Techniques and devices providing adaptivity and personalization in diabetes treatmentINSULET CORP·Filed 2024·Application pending·0 cites
- 3773US2023173173A1Event detection for drug delivery systemINSULET CORP·Filed 2023·Application pending·0 cites
- 3873US2024307618A1Prediction of meal and/or exercise events based on persistent residualsINSULET CORP·Filed 2024·Application pending·0 cites
- 3972US11801344B2Blood glucose rate of change modulation of meal and correction insulin bolus quantityINSULET CORP·Filed 2019·Granted Oct 31, 2023·1 cites·18 claims
- 4072US11565039B2Event detection for drug delivery systemINSULET CORP·Filed 2019·Granted Jan 31, 2023·1 cites·9 claims
- 4172US2023402149A1Switching and customization of glucose prediction models in medicament delivery devicesINSULET CORP·Filed 2023·Application pending·0 cites
- 4271US2024058534A1Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patternsINSULET CORP·Filed 2023·Application pending·0 cites
- 4371US2025144295A1Compensation for missing readings from a glucose monitor in an automated insulin delivery systemINSULET CORP·Filed 2025·Application pending·0 cites
- 4471US2024009393A1Blood glucose rate of change modulation of meal and correction insulin bolus quantityINSULET CORP·Filed 2023·Application pending·0 cites
- 4570US12496398B2Threshold based automatic glucose control responseINSULET CORP·Filed 2022·Granted Dec 16, 2025·0 cites·20 claims
- 4669US2025381345A1Timely alert of impending emptying of medicament storageINSULET CORP·Filed 2025·Application pending·0 cites
- 4769US2024325640A1Methods to incorporate subjective user glucose concentration feedback in automated insulin delivery systemsINSULET CORP·Filed 2024·Application pending·0 cites
- 4868US11684716B2Techniques to reduce risk of occlusions in drug delivery systemsINSULET CORP·Filed 2020·Granted Jun 27, 2023·0 cites·20 claims
- 4968US2024252750A1Devices and methods for initialization of drug delivery devices using measured analyte sensor informationINSULET CORP·Filed 2024·Application pending·0 cites
- 5067US12491316B2Scheduling of medicament bolus deliveries by a medicament delivery device at future dates and times with a computing deviceINSULET CORP·Filed 2021·Granted Dec 9, 2025·0 cites·15 claims
Showing the top 50 of 124 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Joon Bok Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →